東華大學圖書館 |

Ranunculales medicinal plants = biodiversity, chemodiversity and pharmacotherapy /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Ranunculales medicinal plants/ Da-Cheng Hao.
其他題名:	biodiversity, chemodiversity and pharmacotherapy /
作者:	Hao, Da Cheng,
出版者:	London :Academic Press, : 2018.,
面頁冊數:	1 online resource :ill.
內容註:	Intro; Title page; Table of Contents; Copyright; About the Author; Preface; Chapter 1: Genomics and Evolution of Medicinal Plants; Abstract; 1.1. Introduction; 1.2. Evolution of Genome, Gene, and Genotype; 1.3. Mechanisms of Species Evolution and Diversification; 1.4. Phenotype Evolution and Ecology; 1.5. Pharmacophylogeny vs. Pharmacophylogenomics; 1.6. Conclusion and Prospects; Chapter 2: Mining Chemodiversity From Biodiversity: Pharmacophylogeny of Ranunculaceae Medicinal Plants; Abstract; 2.1. Introduction; 2.2. Systematics of Ranunculaceae.
內容註:	2.3. The Chemical Composition of Ranunculoideae Plants2.4. The Chemical Composition of Thalictroideae, Coptidoideae, Hydrastidoideae, and Glaucidioideae; 2.5. Ethnopharmacology and Bioactivity; 2.6. Discussion; 2.7. Conclusion; Chapter 3: Mining Chemodiversity From Biodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants (Except Ranunculaceae); Abstract; 3.1. Introduction; 3.2. Systematics and Evolution of Ranunculales; 3.3. The Chemical Composition of Berberidaceae Plants; 3.4. The Chemical Composition of Menispermaceae.
內容註:	3.5. The Chemical Composition of Lardizabalaceae and Circaeasteraceae Plants3.6. The Chemical Composition of Papaveraceae and Eupteleaceae Plants; 3.7. Ethnopharmacology and Bioactivity; 3.8. Discussion and Conclusion; Chapter 4: Drug Metabolism and Pharmacokinetic Diversity of Ranunculaceae Medicinal Compounds; Abstract; Abbreviations; 4.1. Introduction; 4.2. Absorption of Ranunculaceae Compounds; 4.3. Distribution; 4.4. Metabolism; 4.5. Toxicity; 4.6. Pharmacokinetics and Pharmacodynamics; 4.7. Conclusion and Prospect.
內容註:	Chapter 5: Drug Metabolism and Disposition Diversity of Ranunculales PhytometabolitesAbstract; Abbreviations; 5.1. Introduction; 5.2. Absorption; 5.3. Distribution; 5.4. Metabolism; 5.5. Excretion and Elimination; 5.6. Toxicity and Safety; 5.7. Pharmacokinetics and Pharmacodynamics; 5.8. Conclusions and Prospect; Chapter 6: Anticancer Chemodiversity of Ranunculaceae Medicinal Plants; Abstract; Abbreviations; 6.1. Introduction; 6.2. Cell Death Pathways; 6.3. MicroRNAs, DNA Damage, and Epigenetic Regulation; 6.4. Oxidative Process and Metabolism; 6.5. Antiangiogenic and Antimetastatic Effects.
內容註:	6.6. Immunomodulatory Activity6.7. Antiinflammatory Activity; 6.8. Structure-Activity Relationship; 6.9. Genomics, Transcriptomics, Proteomics, and Metabolomics; 6.10. Conclusion and Future Perspective; Chapter 7: Biodiversity, Chemodiversity, and Pharmacotherapy of Thalictrum Medicinal Plants; Abstract; 7.1. Introduction; 7.2. Chemical Constituents; 7.3. Bioactivity; 7.4. Phylogeny; 7.5. Discussion and Conclusion; Chapter 8: Biodiversity, Chemodiversity, and Pharmacotherapy of Anemone Medicinal Plants; Abstract; Abbreviations; 8.1. Introduction; 8.2. Ethnopharmacology.
標題:	Ranunculales. -
電子資源:	https://www.sciencedirect.com/science/book/9780128142325
ISBN:	9780128142332 (electronic bk.)

Ranunculales medicinal plants = biodiversity, chemodiversity and pharmacotherapy /
Hao, Da Cheng,

Ranunculales medicinal plantsbiodiversity, chemodiversity and pharmacotherapy /[electronic resource] :Da-Cheng Hao. - London :Academic Press,2018. - 1 online resource :ill.

Includes bibliographical references and index.

Intro; Title page; Table of Contents; Copyright; About the Author; Preface; Chapter 1: Genomics and Evolution of Medicinal Plants; Abstract; 1.1. Introduction; 1.2. Evolution of Genome, Gene, and Genotype; 1.3. Mechanisms of Species Evolution and Diversification; 1.4. Phenotype Evolution and Ecology; 1.5. Pharmacophylogeny vs. Pharmacophylogenomics; 1.6. Conclusion and Prospects; Chapter 2: Mining Chemodiversity From Biodiversity: Pharmacophylogeny of Ranunculaceae Medicinal Plants; Abstract; 2.1. Introduction; 2.2. Systematics of Ranunculaceae.

Ranunculales is an order of flowering plants belonging to a paraphyletic group known as the basal eudicots. Medicinal plants of this order provide myriad pharmaceutically active components commonly used worldwide in ethnomedicine and traditional Chinese medicine. Interest in plant-based medicinal resources has led to discoveries of many novel compounds in various species, and to investigations on their chemodiversity, biodiversity and pharmacotherapy. Ranunculales Medicinal Plants covers this order of flowering plants comprehensively in this context; detailing the phytochemistry, chemotaxonomy, molecular biology, and phylogeny of selected medicinal plants families and genera, and their relevance to drug efficacy. The book carries out an exhaustive survey of the literature in order to characterize global trends in the application of flexible technologies. The interrelationship between Chinese species and between Chinese and non-Chinese species is inferred, in the text, through molecular phylogeny, based on nuclear and chloroplast DNA sequencing. The title discusses the conflict between chemotaxonomy and molecular phylogeny, in the context of drug discovery and development. It offers invaluable and holistic coverage for the study of Ranunculales as a pharmaceutical resource.

ISBN: 9780128142332 (electronic bk.)Subjects--Topical Terms:

3462533
Ranunculales.
Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: QK495.A12

Dewey Class. No.: 583/.34

Ranunculales medicinal plants = biodiversity, chemodiversity and pharmacotherapy /
LDR:05161cmm a2200325 a 4500 001 2223273
006 o d
007 cnu|unuuu||
008 210114s2018 enka ob 001 0 eng d
020 $a 9780128142332 (electronic bk.)
020 $a 0128142332 (electronic bk.)
020 $a 9780128142325
020 $a 0128142324
035 $a (OCoLC)1032810230
035 $a EL2020003
040 $a N$T $b eng $c N$T $d N$T $d EBLCP $d OPELS $d YDX $d OCLCQ $d D6H $d CASUM $d OCLCO $d OCLCF $d MERER $d OCLCQ $d NLE $d INT $d OCLCQ $d U3W $d LVT $d TKN $d DEBBG $d OCLCQ $d OCLCO $d OCLCA $d UKAHL $d OCLCA
041 0 $a eng
050 4 $a QK495.A12
082 0 4 $a 583/.34
100 1 $a Hao, Da Cheng, $e author. $3 3462532
245 1 0 $a Ranunculales medicinal plants $h [electronic resource] : $b biodiversity, chemodiversity and pharmacotherapy / $c Da-Cheng Hao.
260 $a London : $b Academic Press, $c 2018.
300 $a 1 online resource : $b ill.
504 $a Includes bibliographical references and index.
505 0 $a Intro; Title page; Table of Contents; Copyright; About the Author; Preface; Chapter 1: Genomics and Evolution of Medicinal Plants; Abstract; 1.1. Introduction; 1.2. Evolution of Genome, Gene, and Genotype; 1.3. Mechanisms of Species Evolution and Diversification; 1.4. Phenotype Evolution and Ecology; 1.5. Pharmacophylogeny vs. Pharmacophylogenomics; 1.6. Conclusion and Prospects; Chapter 2: Mining Chemodiversity From Biodiversity: Pharmacophylogeny of Ranunculaceae Medicinal Plants; Abstract; 2.1. Introduction; 2.2. Systematics of Ranunculaceae.
505 8 $a 2.3. The Chemical Composition of Ranunculoideae Plants2.4. The Chemical Composition of Thalictroideae, Coptidoideae, Hydrastidoideae, and Glaucidioideae; 2.5. Ethnopharmacology and Bioactivity; 2.6. Discussion; 2.7. Conclusion; Chapter 3: Mining Chemodiversity From Biodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants (Except Ranunculaceae); Abstract; 3.1. Introduction; 3.2. Systematics and Evolution of Ranunculales; 3.3. The Chemical Composition of Berberidaceae Plants; 3.4. The Chemical Composition of Menispermaceae.
505 8 $a 3.5. The Chemical Composition of Lardizabalaceae and Circaeasteraceae Plants3.6. The Chemical Composition of Papaveraceae and Eupteleaceae Plants; 3.7. Ethnopharmacology and Bioactivity; 3.8. Discussion and Conclusion; Chapter 4: Drug Metabolism and Pharmacokinetic Diversity of Ranunculaceae Medicinal Compounds; Abstract; Abbreviations; 4.1. Introduction; 4.2. Absorption of Ranunculaceae Compounds; 4.3. Distribution; 4.4. Metabolism; 4.5. Toxicity; 4.6. Pharmacokinetics and Pharmacodynamics; 4.7. Conclusion and Prospect.
505 8 $a Chapter 5: Drug Metabolism and Disposition Diversity of Ranunculales PhytometabolitesAbstract; Abbreviations; 5.1. Introduction; 5.2. Absorption; 5.3. Distribution; 5.4. Metabolism; 5.5. Excretion and Elimination; 5.6. Toxicity and Safety; 5.7. Pharmacokinetics and Pharmacodynamics; 5.8. Conclusions and Prospect; Chapter 6: Anticancer Chemodiversity of Ranunculaceae Medicinal Plants; Abstract; Abbreviations; 6.1. Introduction; 6.2. Cell Death Pathways; 6.3. MicroRNAs, DNA Damage, and Epigenetic Regulation; 6.4. Oxidative Process and Metabolism; 6.5. Antiangiogenic and Antimetastatic Effects.
505 8 $a 6.6. Immunomodulatory Activity6.7. Antiinflammatory Activity; 6.8. Structure-Activity Relationship; 6.9. Genomics, Transcriptomics, Proteomics, and Metabolomics; 6.10. Conclusion and Future Perspective; Chapter 7: Biodiversity, Chemodiversity, and Pharmacotherapy of Thalictrum Medicinal Plants; Abstract; 7.1. Introduction; 7.2. Chemical Constituents; 7.3. Bioactivity; 7.4. Phylogeny; 7.5. Discussion and Conclusion; Chapter 8: Biodiversity, Chemodiversity, and Pharmacotherapy of Anemone Medicinal Plants; Abstract; Abbreviations; 8.1. Introduction; 8.2. Ethnopharmacology.
520 $a Ranunculales is an order of flowering plants belonging to a paraphyletic group known as the basal eudicots. Medicinal plants of this order provide myriad pharmaceutically active components commonly used worldwide in ethnomedicine and traditional Chinese medicine. Interest in plant-based medicinal resources has led to discoveries of many novel compounds in various species, and to investigations on their chemodiversity, biodiversity and pharmacotherapy. Ranunculales Medicinal Plants covers this order of flowering plants comprehensively in this context; detailing the phytochemistry, chemotaxonomy, molecular biology, and phylogeny of selected medicinal plants families and genera, and their relevance to drug efficacy. The book carries out an exhaustive survey of the literature in order to characterize global trends in the application of flexible technologies. The interrelationship between Chinese species and between Chinese and non-Chinese species is inferred, in the text, through molecular phylogeny, based on nuclear and chloroplast DNA sequencing. The title discusses the conflict between chemotaxonomy and molecular phylogeny, in the context of drug discovery and development. It offers invaluable and holistic coverage for the study of Ranunculales as a pharmaceutical resource.
588 0 $a Vendor-supplied metadata.
650 0 $a Ranunculales. $3 3462533
650 1 2 $a Herbal Medicine. $3 1363291
650 1 2 $a Plants, Medicinal. $3 545849
650 2 2 $a Berberidaceae $x chemistry. $3 3462534
650 2 2 $a Berberidaceae $x drug effects. $3 3462535
650 2 2 $a Menispermaceae $x chemistry. $3 3462536
650 2 2 $a Menispermaceae $x drug effects. $3 3462537
650 2 2 $a Papaveraceae $x chemistry. $3 3462538
650 2 2 $a Papaveraceae $x drug effects. $3 3462539
650 2 2 $a Ranunculaceae $x chemistry. $3 3462540
650 2 2 $a Ranunculaceae $x drug effects. $3 3462541
655 4 $a Electronic books. $2 lcsh $3 542853
856 4 0 $u https://www.sciencedirect.com/science/book/9780128142325